Dorzolamide: Development and clinical application of a topical carbonic anhydrase inhibitor
- 1 September 1997
- journal article
- review article
- Published by Elsevier in Survey of Ophthalmology
- Vol. 42 (2) , 137-151
- https://doi.org/10.1016/s0039-6257(97)00053-2
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Studies of Topical Carbonic Anhydrase Inhibitors: Ocular Hypotensive Effect of Thiadiazole DerivativesJournal of Ocular Pharmacology and Therapeutics, 1993
- Sezolamide: Additivity to timolol twice dailyEye, 1992
- Indirect chiral separation and analyses in human biological fluids of the stereoisomers of a thienothiopyran-2-sulfonamide (TRUSOPT), a novel carbonic anhydrase inhibitor with two chiral centers in the moleculeChirality, 1992
- TREATMENT OF CYSTOID MACULAR EDEMA WITH ACETAZOLAMIDE IN A PATIENT WITH SERPIGINOUS CHOROIDOPATHYRetina, 1991
- Effects of ambient bicarbonate, phosphate and carbonic anhydrase inhibitors on fluid transport across rabbit corneal endotheliumExperimental Eye Research, 1990
- Renal tubular acidosis and skeletal demineralization in patients on long-term anticonvulsant therapyThe Journal of Pediatrics, 1975
- Teratogenesis of acetazolamide in the CBA/J and SWV strains of mice. I. TeratologyTeratology, 1975
- Teratogenic action of acetazolamide in golden hamstersTeratology, 1971
- ACETAZOLAMIDE AND RENAL STONE FORMATIONThe Lancet, 1970
- Fatal pancytopenia and acetazolamide therapyPublished by American Medical Association (AMA) ,1969